Atlas Trials

ADMA Biologics, Inc.

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch ADMA Biologics, Inc.

RecordFirmDate
An Open Label, Multicenter Study to Evaluate the Pharmacokinetics, Efficacy and Safety of ASCENIV™ (IGIV) in Pediatric Subjects With Primary Immunodeficiency Diseases (PIDD) (NCT05070455)ADMA Biologics, Inc.2022-09-01

Track ADMA Biologics, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.